Patent details
EP2249765
Title:
Dapsone to treat rosacea
Basic Information
- Publication number:
- EP2249765
- PCT Application Number:
- US2008002549
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP087261293
- PCT Publication Number:
- WO2009108147
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Dapsone to treat rosacea
- French Title of Invention:
- Dapsone pour traiter la rosacée
- German Title of Invention:
- Dapson zur Behandlung von Rosacea
- SPC Number:
-
Dates
- Filing date:
- 27/02/2008
- Grant date:
- 13/11/2019
- EP Publication Date:
- 17/11/2010
- PCT Publication Date:
- 03/09/2009
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 13/11/2019
- EP B1 Publication Date:
- 13/11/2019
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 27/02/2020
- Expiration date:
- 27/02/2028
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 06/11/2019
-
-
- Name:
- ALLERGAN, INC.
- Address:
- 2525 Dupont Drive, Irvine, CA 92612, United States (US)
Inventor
- Name:
- GARRETT, John Steven
- Address:
- United States (US)
Classification
- IPC classification:
-
A61K 8/46;
A61K 9/00;
A61K 9/06;
A61K 31/145;
A61K 47/32;
A61P 17/10;
A61Q 19/00;
Publication
European Patent Bulletin
- Issue number:
- 201946
- Publication date:
- 13/11/2019
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
-
- Annual Fee Number:
-
- Expected Payer:
-
- Last Annual Fee Payment Date:
-
- Last Annual Fee Paid Number:
-
- Payer:
-
Filing date |
Document type |
Number of pages |